SEP 21, 2017 10:29 AM PDT

Immune Cells Patch Up Holes in the Gut

WRITTEN BY: Kara Marker

Immune cells are capable of making repairs in an intestine damaged by inflammatory bowel diseases. Either by boosting the activity of these cells or mimicking their reparative mechanisms, researchers believe they can develop a new treatment for those afflicted.

Credit: Georgia State University

Inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis, is generally characterized by a disruption of the integrity of the intestinal epithelial barrier, a layer of tissue that prevents things traveling through the gut from reaching the rest of the body. Bacteria enter the intestine, breeze through the barrier, and trigger an immune response, causing excessive inflammation indicative of inflammatory bowel disease.

Thus, repairing the epithelial barrier is vital for healing the intestines and ridding the body of this disease. From Georgia State University, researchers found that immune cells called macrophages can produce interleukin 10 (IL-10), which works as a healing factor in the context of inflammatory bowel disease. IL-10 works its magic by interacting with receptors on intestinal epithelial cells to promote wound healing.

“We tried to understand some of the cellular mechanisms that are required for optimal wound healing in the intestine,” explained Dr. Dim Denning. “To do this, we used a cutting-edge system, a colonoscope with biopsy forceps, to create a wound in mice.”

Denning’s system used in mice mimics colonoscopies commonly conducted in humans. “This cutting-edge system allowed us to begin to define what cells and factors contribute to wound healing in the mouse model,” Denning said.

Specifically, Denning and his team compared normal (wild-type) mice with mice genetically deficient in IL-10, particularly the macrophages, looking at the ability of each group to repair epithelial wounds. Without IL-10, the mice were largely inept at wound-healing in the intestines.

Based on this finding, Denning believes that there is potential for new therapeutic interventions for people with inflammatory bowel disease.

"There are different ways we think about it, but perhaps we could deliver the beneficial compounds (IL-10 and the downstream signaling pathways) to those patients, orally or even intravenously, or somehow drive the natural production of those compounds,” he said.

The present study was published in The Journal of Clinical Investigation.

Sources: Georgia State University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 07, 2019
Microbiology
JUL 07, 2019
The Right Cocktail of Gut Microbes may Prevent or Reverse Food Allergies
Food allergies are a growing public health concern. New work may help pave the way for a therapeutic that reduces or stops allergies....
NOV 03, 2019
Genetics & Genomics
NOV 03, 2019
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
NOV 22, 2019
Immunology
NOV 22, 2019
Rogue Inflammation Activates Depression During Pregnancy
Unresolved inflammation in a pregnant woman’s body can lead to serious depression during and after pregnancy. A new study investigates the physiologi...
NOV 27, 2019
Immunology
NOV 27, 2019
Playing "Tag" with the Immune System
Human cells employ an intricate tagging system to manage protein activity in the body. By “tagging” a protein with a certain modification, cell...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
JAN 22, 2020
Cancer
JAN 22, 2020
How the VISTA molecule affects immune responses
A new study describes how a molecule named VISTA has been impeding immune responses in cancer therapies. By turning this molecule “off,” resear...
Loading Comments...